Olopatadine Hydrochloride 72657-0194-11
- Manufacturer
- Glenmark Therapeutics Inc., Usa
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- February 28, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA219557
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
72657-0194-11Selected2 BOTTLE, PLASTIC in 1 CARTON (72657-194-11) / 2.5 mL in 1 BOTTLE, PLASTIC
Other packages for this product(1)
1 BOTTLE, PLASTIC in 1 CARTON (72657-194-25) / 2.5 mL in 1 BOTTLE, PLASTIC